(R)-tert-Butyl (1-(4-methoxybenzyl)pyrrolidin-3-yl)carbamate

Catalog No.: 
ACIRCH411
CAS No.: 
1286207-21-3
Molecular Formula: 
C17H26N2O3
Molecular Weight: 
306.41
(R)-tert-Butyl (1-(4-methoxybenzyl)pyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$312.00InquiryInquiry
250mg95%$507.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-(4-methoxybenzyl)pyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(1-(4-methoxybenzyl)pyrrolidin-3-yl)carbamate
MDL No.MFCD18378075
Molecular FormulaC17H26N2O3
Molecular Weight306.41
SMILESO=C(OC(C)(C)C)N[C@H]1CN(CC2=CC=C(OC)C=C2)CC1
InChI KeyKMEQFESYHWODBD-CQSZACIVSA-N
Synonym(R)-tert-Butyl 1-(4-methoxybenzyl)pyrrolidin-3-ylcarbamate;Carbamic acid, N-[(3R)-1-[(4-methoxyphenyl)methyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1286207-21-3

Synthetic Route by SureRoute

1. ACIRCH411 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9In Stock
  2. Plus
  3. ACQMXG193 route compound structure diagram
    ACQMXG193123-11-5In Stock
  4. Then
  5. ACIRCH411 route product structure diagram
    ACIRCH4111286207-21-3
Inquiry

2. ACIRCH411 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRCH411 route product structure diagram
    ACIRCH4111286207-21-3
Inquiry

3. ACIRCH411 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRCH411 route product structure diagram
    ACIRCH4111286207-21-3
Inquiry

Comments (0)